Phytotherapeutic agents in the management of symptomatic benign prostatic hyperplasia.
Phytotherapeutic agents constitute a large part of the market for the pharmacological treatment of symptomatic BPH. At present, these agents are being used on an empirical basis with some success in relieving symptoms. They have not been shown to have any effect on objective indices. Several agents are presently undergoing randomized trials.